Conformis Pivots to Standard Knees Amid ASC Growth

Conformis logo

Conformis reported 2Q20 orthopedic revenue of USD $19.5 million, -0.6% vs. 2Q19. Nearly half the company's revenue for the quarter came from royalties paid by Zimmer Biomet in a settlement concerning patient-specific instrument patents. Conformis' product revenue declined by -51.5% in the second quarter. The company remains on track to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us